Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Arzneimittel-Forschung
|
January 1, 1978
[Differentiating the action of cataleptogenic bodies (author's transl)]
H G Menge, U Brand
Arzneimittel-Forschung
|
January 1, 1982
[Summarizing description of the pharmacology of budipine, a new 4,4-diphenylpiperidine derivative used in Parkinson therapy (author's transl)]
H G Menge, U Brand
Psychopharmacologia
|
January 1, 1971
[Stereotypy following amphetamine and apomorphine and its influencing by drugs]
H G Menge, U Brand
Arzneimittel-Forschung
|
May 1, 1989
Effects of the antiparkinson drug budipine on EEG activity in unrestrained rats
W Dimpfel, M Spüler, H G Menge
Arzneimittel-Forschung
|
January 1, 1978
[Methods for detecting "cataleptic states" in the rat]
U Brand, E C Dittmann, H G Menge
Pharmacopsychiatry
|
November 1, 1989
Pharmacological studies on perazine and its primary metabolites
U Brand, H G Menge, B W Neumann, et al.
Neuroscience Letters
|
June 12, 1981
Effects of chronic amphetamine treatment on the glutamate concentration in cerebrospinal fluid and brain: implications for a theory of schizophrenia
J S Kim, H H Kornhuber, U Brand, et al.
Arzneimittel-Forschung
|
January 1, 1984
[Synthesis, physical-chemical properties and pharmacologically-oriented screening studies on budipine and related 4,4-diphenylpiperidines]
H Schaefer, G Hackmack, K Eistetter, et al.
Arzneimittel-Forschung
|
January 1, 1977
[Studies on the effect of urapidil on the central nervous system and various organ functions in animal experiments (author's transl)]
W Schoetensack, M Eltze, S Gönne, et al.
Arzneimittel-Forschung
|
January 1, 1977
[Toxicologic study on the antihypertensive agent urapidil]
J König, E D Meier-Dörzenbach, H G Menge, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Arzneimittel-Forschung
|
January 1, 1978
[Differentiating the action of cataleptogenic bodies (author's transl)]
H G Menge, U Brand
Arzneimittel-Forschung
|
January 1, 1982
[Summarizing description of the pharmacology of budipine, a new 4,4-diphenylpiperidine derivative used in Parkinson therapy (author's transl)]
H G Menge, U Brand
Psychopharmacologia
|
January 1, 1971
[Stereotypy following amphetamine and apomorphine and its influencing by drugs]
H G Menge, U Brand
Arzneimittel-Forschung
|
May 1, 1989
Effects of the antiparkinson drug budipine on EEG activity in unrestrained rats
W Dimpfel, M Spüler, H G Menge
Arzneimittel-Forschung
|
January 1, 1978
[Methods for detecting "cataleptic states" in the rat]
U Brand, E C Dittmann, H G Menge
Pharmacopsychiatry
|
November 1, 1989
Pharmacological studies on perazine and its primary metabolites
U Brand, H G Menge, B W Neumann, et al.
Neuroscience Letters
|
June 12, 1981
Effects of chronic amphetamine treatment on the glutamate concentration in cerebrospinal fluid and brain: implications for a theory of schizophrenia
J S Kim, H H Kornhuber, U Brand, et al.
Arzneimittel-Forschung
|
January 1, 1984
[Synthesis, physical-chemical properties and pharmacologically-oriented screening studies on budipine and related 4,4-diphenylpiperidines]
H Schaefer, G Hackmack, K Eistetter, et al.
Arzneimittel-Forschung
|
January 1, 1977
[Studies on the effect of urapidil on the central nervous system and various organ functions in animal experiments (author's transl)]
W Schoetensack, M Eltze, S Gönne, et al.
Arzneimittel-Forschung
|
January 1, 1977
[Toxicologic study on the antihypertensive agent urapidil]
J König, E D Meier-Dörzenbach, H G Menge, et al.
Page
of 1